Jonas Wang BSPh, PhD

Jonas Wang is the CEO and president of Stemcyte International Ltd. Stemcyte, which Dr. Wang joined in January of 2009, is expected to go public in Taiwan later this year. He is also currently a consultant partner of Sycamore Ventures in New Jersey, focusing on life sciences and biotechnology investments.

Dr. Wang has over 30 years of experience in pharmaceutical R&D management and business development. Prior to joining Sycamore Ventures, he was vice president of Research and Technology at Johnson & Johnson Consumer Products and a corporate director of J&J Drug Delivery Technology Resource Center (TRC), responsible for new product technology, patent strategy, competitive intelligence, and new measurement methodology for skin and hair care franchise. Prior to that, Dr. Wang was an associate director of Basic Pharmaceutics, the Pharmaceutical Research Institute of Bristol-Myers Squibb Co. Additionally, in 2001, he participated at the Congressional Business Summit in Washington, DC, leading the group exploring emerging markets in America.